Autoimmune Diseases Overview and Mechanisms
Overview of Autoimmune Diseases
Definition: Autoimmune diseases are a group of 60 to 80 chronic inflammatory diseases characterized by a misdirected immune response.
Prevalence: Affects 5% to 8% of the population in the US, with a higher prevalence in females (75% of cases).
Classification of Immune Disorders
Immunodeficiency: Too little immune response.
Hypersensitivity: Too much immune response.
Autoimmunity: Misdirected response against self.
Mechanism of Autoimmunity
Auto/self antigens: Antigens that are part of the body itself, can be altered by bacteria, viruses, or chemicals.
Immune response can originate from:
Humoral response (autoantibodies).
Cell-mediated response (auto-reactive T cells).
Initial immune tolerance failure can lead to sustained autoimmune response.
Development of Autoimmune Diseases
Triggered by a combination of genetic susceptibility, environmental factors, and breakdown of natural tolerance mechanisms.
Dysfunctional self-tolerance can lead to immune attack on the body's own tissues.
Genetic and Environmental Factors
Genetic Factors: Genes involved include those affecting immune regulation (e.g., CTLA-4).
Environmental Triggers: Infections, drugs, and stress can precipitate or exacerbate autoimmunity.
Central Tolerance and Autoimmunity
Central tolerance: Process in the thymus and bone marrow where self-reactive lymphocytes are eliminated.
Defects in central tolerance (e.g., AIRE gene) can lead to significant autoimmune disorders.
Molecular Mechanisms
Molecular Mimicry: Antibodies against foreign antigens can cross-react with self-antigens, leading to autoimmune responses (e.g., rheumatic fever).
Multi-Valent Antigens: How self-reactive B cells can become activated under certain conditions (e.g., immune complexes).
Immune Responses to Autoimmunity
Primary Mechanisms of Damage:
Type II: Antibodies against cell surface antigens. Examples: Autoimmune hemolytic anemia, Graves disease.
Type III: Immune complex formation leading to systemic lupus erythematosus (SLE).
Type IV: T cell-mediated responses, such as in Type 1 Diabetes and multiple sclerosis.
Examples of Autoimmune Diseases
Multiple Sclerosis: T cell-driven destruction of myelin.
Graves’ Disease: Autoantibodies stimulate hyperthyroidism.
Systemic Lupus Erythematosus: Autoantibodies against nuclear components resulting in widespread inflammation and damage.
Myasthenia Gravis: Autoantibodies against acetylcholine receptors causing muscle weakness.
Diagnostics of Autoimmune Diseases
General inflammatory markers: Elevated erythrocyte sedimentation rate, CRP levels.
Detection methods for autoantibodies include immunofluorescence, ELISA, western blot, and radioimmunoprecipitation.
Therapeutic Approaches
Plasmapheresis: Used to remove circulating antibodies.
Immunosuppression: Corticosteroids and other drugs that inhibit immune response.
Organ-specific treatments, like insulin for Type 1 Diabetes or acetylcholinesterase inhibitors for Myasthenia Gravis.
Conclusion
Autoimmune diseases represent a significant healthcare challenge, with complex genetic and environmental interactions. Understanding the mechanisms underlying these disorders is essential for developing effective treatments.
Overview of Autoimmune Diseases
Definition: Autoimmune diseases are a group of 60 to 80 chronic inflammatory diseases characterized by a misdirected immune response.
Autoimmune Disease: A medical condition in which the immune system mistakenly attacks the body’s own healthy cells, tissues, or organs as if they were foreign invaders.
Prevalence: Affects 5% to 8% of the population in the US, with a higher prevalence in females (75% of cases).
Prevalence: The proportion of a population found to have a condition (in this case, autoimmune diseases) at a specific time.
Classification of Immune Disorders
Immunodeficiency: A condition in which the immune system's ability to fight infectious disease is compromised or entirely absent.
Primary Immunodeficiency: Genetic disorders that are present at birth or develop in childhood.
Secondary Immunodeficiency: Immune dysfunction caused by external factors, such as infections (e.g., HIV/AIDS) or medications (e.g., chemotherapy).
Hypersensitivity: An exaggerated immune response to an antigen that leads to tissue damage. This can include allergic reactions.
Autoimmunity: A process in which the immune system causes damage to the body by attacking its own cells.
Mechanism of Autoimmunity
Auto/self antigens: Antigens that are part of the body itself and may be recognized as foreign during an autoimmune response.
Humoral Response: The aspect of immunity that is mediated by secreted antibodies produced by B cells, which recognize and bind to specific antigens.
Cell-mediated Response: Immunity that involves the activation of T cells, which directly attack and destroy infected or transforming cells.
Initial Immune Tolerance Failure: The inability of the immune system to recognize self-antigens, potentially leading to autoimmune diseases.
Development of Autoimmune Diseases
Genetic Susceptibility: The increased likelihood of developing an autoimmune disease due to genetic factors and inherited traits.
Environmental Factors: External influences that can trigger autoimmune diseases, including infections, chemicals, or physical stress.
Breakdown of Natural Tolerance Mechanisms: The failure of the immune system to distinguish between self and non-self, leading to an autoimmune attack.
Genetic and Environmental Factors
Genes affecting Immune Regulation: Specific genes, like CTLA-4, that control the immune response and are linked to susceptibility to autoimmune diseases.
Environmental Triggers: Factors such as infections, drugs, and stress that can initiate or worsen autoimmune conditions.
Central Tolerance and Autoimmunity
Central Tolerance: The process through which the immune system eliminates self-reactive T and B cells during their development to prevent autoimmunity.
Defects in Central Tolerance: Genetic or developmental abnormalities that impair the elimination of self-reactive lymphocytes, leading to autoimmune diseases.
Molecular Mechanisms
Molecular Mimicry: The phenomenon where foreign antigens share structural similarities with self-antigens, causing an autoimmune response against self-tissues (e.g., rheumatic fever).
Multi-Valent Antigens: These are antigens that contain multiple epitopes, which may activate self-reactive B cells under particular conditions.
Immune Responses to Autoimmunity
Primary Mechanisms of Damage: Different pathways through which autoimmune diseases cause harm to the body.
Type II Hypersensitivity: Immune reactions that involve the binding of antibodies to cell surface antigens, leading to cell damage or dysfunction. Examples include autoimmune hemolytic anemia and Graves disease.
Type III Hypersensitivity: This involves immune complex formation, which can deposit in tissues and lead to inflammation, as seen in systemic lupus erythematosus (SLE).
Type IV Hypersensitivity: T cell-mediated immune responses that result in tissue damage, seen in conditions like Type 1 Diabetes and multiple sclerosis.
Examples of Autoimmune Diseases
Multiple Sclerosis: A disease characterized by the destruction of myelin sheaths surrounding nerve fibers by T cells.
Graves’ Disease: An autoimmune disorder where the immune system stimulates the thyroid to produce excessive amounts of thyroid hormones.
Systemic Lupus Erythematosus: A systemic autoimmune disease resulting in the production of autoantibodies against various components of the cell nucleus, leading to widespread inflammation.
Myasthenia Gravis: An autoimmune neuromuscular disorder caused by autoantibodies against acetylcholine receptors at the neuromuscular junction, resulting in muscle weakness.
Diagnostics of Autoimmune Diseases
General Inflammatory Markers: Indicators of inflammation in the body include elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels.
Detection Methods for Autoantibodies: Diagnostic tests like immunofluorescence, ELISA (enzyme-linked immunosorbent assay), western blot, and radioimmunoprecipitation are used to identify specific autoantibodies in patients.
Therapeutic Approaches
Plasmapheresis: A procedure that removes circulating antibodies from the blood to alleviate autoimmune symptoms.
Immunosuppression: Treatment strategies that suppress the immune response using corticosteroids and other drugs, helping to control autoimmune activity.
Organ-specific Treatments: Therapies designed to target specific autoimmune conditions, such as administering insulin for Type 1 Diabetes or acetylcholinesterase inhibitors for enhancing muscle contraction in Myasthenia Gravis.
Conclusion
Autoimmune diseases represent a significant healthcare challenge, with complex genetic and environmental interactions. Understanding the mechanisms underlying these disorders is essential for developing effective treatments.